
Experts believe that Elon Musk-led neurotechnology company Neuralink lacks transparency, while openly disregarding scientific and ethical norms.
Neuralink raises concerns about patient safety and could end up setting back the entire field of neurotechnology, experts told Forbes, after the billionaire announced early success in the company's first human trial.